BENAROYA RESEARCH INSTITUTE
๐บ๐ธUnited States
A Pilot Study to Evaluate Barhemsys for the Prevention of Postoperative Nausea and Vomiting in the Bariatric Surgery Population
Phase 3
Not yet recruiting
- Conditions
- Post Operative Nausea and Vomiting
- Interventions
- Drug: Amisulpride IV TreatmentDrug: Amisulpride IV PreventionDrug: Placebo PreventativeDrug: Placebo Treatment
- First Posted Date
- 2024-09-05
- Last Posted Date
- 2024-09-05
- Lead Sponsor
- Benaroya Research Institute
- Target Recruit Count
- 100
- Registration Number
- NCT06585540
- Locations
- ๐บ๐ธ
Virginia Mason Medical Center, Seattle, Washington, United States
Intradetrusor Botox at the Time of Transurethral Resection of the Prostate for Mixed Lower Urinary Tract Symptoms
Withdrawn
- Conditions
- Transurethral Resection of the Prostate
- First Posted Date
- 2024-08-01
- Last Posted Date
- 2024-08-01
- Lead Sponsor
- Benaroya Research Institute
- Registration Number
- NCT06531655
- Locations
- ๐บ๐ธ
Virginia Mason Medical Center, Seattle, Washington, United States
Temporal Variation in Exhaled Volatile Organic Compounds in Esophageal Cancer Patients
Not Applicable
Completed
- Conditions
- Esophageal Cancer
- Interventions
- Other: Exhaled VOC breath test
- First Posted Date
- 2024-06-12
- Last Posted Date
- 2024-08-27
- Lead Sponsor
- Benaroya Research Institute
- Target Recruit Count
- 46
- Registration Number
- NCT06453993
- Locations
- ๐ฌ๐ง
Imperial College London, London, United Kingdom
๐บ๐ธVirginia Mason Medical Center, Seattle, Washington, United States
Influence of Nutrition and Sarcopenia on Esophageal Cancer Outcomes
Completed
- Conditions
- Esophageal CancerSarcopenia
- First Posted Date
- 2024-03-18
- Last Posted Date
- 2024-05-24
- Lead Sponsor
- Benaroya Research Institute
- Target Recruit Count
- 1717
- Registration Number
- NCT06314516
- Locations
- ๐บ๐ธ
Virginia Mason Medical Center, Seattle, Washington, United States
Do Patient Educational Videos Improve Pain and Recovery After Laparoscopic Hysterectomy?
Not Applicable
Completed
- Conditions
- Pain, Postoperative
- Interventions
- Behavioral: Educational Video
- First Posted Date
- 2024-02-20
- Last Posted Date
- 2024-08-23
- Lead Sponsor
- Benaroya Research Institute
- Target Recruit Count
- 94
- Registration Number
- NCT06265376
- Locations
- ๐บ๐ธ
Virginia Mason Medical Center, Seattle, Washington, United States
Optimal Effective Local Anesthetic Volume for Pain Relief Using Brachial Plexus Block
Phase 4
Recruiting
- Conditions
- Post Operative Pain
- Interventions
- Drug: Dose of 0.5% Ropivacaine
- First Posted Date
- 2023-05-22
- Last Posted Date
- 2023-05-22
- Lead Sponsor
- Benaroya Research Institute
- Target Recruit Count
- 150
- Registration Number
- NCT05868993
- Locations
- ๐บ๐ธ
Virginia Mason Medical Center, Seattle, Washington, United States
Targeting Beta Cell Dysfunction With Verapamil in Longstanding T1D
- First Posted Date
- 2023-05-06
- Last Posted Date
- 2023-05-06
- Lead Sponsor
- Benaroya Research Institute
- Target Recruit Count
- 10
- Registration Number
- NCT05847413
- Locations
- ๐บ๐ธ
Benaroya Research Institute, Seattle, Washington, United States
Immune Effects of Vedolizumab With or Without Anti-TNF Pre-treatment in T1D
- First Posted Date
- 2022-03-16
- Last Posted Date
- 2024-05-24
- Lead Sponsor
- Benaroya Research Institute
- Target Recruit Count
- 20
- Registration Number
- NCT05281614
- Locations
- ๐บ๐ธ
University of California San Diego, La Jolla, California, United States
๐บ๐ธBenaroya Research Institute, Seattle, Washington, United States
Pre-operative Education Modalities to Decrease Opioid Use
Not Applicable
Recruiting
- Conditions
- Opioid-Related DisordersProstatectomy
- Interventions
- Behavioral: Pre-operative Opioid Education
- First Posted Date
- 2021-06-21
- Last Posted Date
- 2023-12-21
- Lead Sponsor
- Benaroya Research Institute
- Target Recruit Count
- 60
- Registration Number
- NCT04933084
- Locations
- ๐บ๐ธ
Virginia Mason Medical Center, Seattle, Washington, United States
Defining Normal Postoperative Magnetic Resonance Imaging After Total Knee Arthroplasty
Completed
- Conditions
- Local Anesthetic ComplicationLocal Anesthetic Drug Adverse Reaction
- First Posted Date
- 2021-03-29
- Last Posted Date
- 2021-05-25
- Lead Sponsor
- Benaroya Research Institute
- Target Recruit Count
- 36
- Registration Number
- NCT04821245
- Locations
- ๐บ๐ธ
Benaroya Research Institute, Seattle, Washington, United States
ยฉ Copyright 2025. All Rights Reserved by MedPath